Chronic myeloid leukaemia – Life with Disease

Go back

Chronic myeloid leukemia is a slowly developing blood cancer that affects white blood cells in the bone marrow. While it can feel overwhelming to receive this diagnosis, modern treatments have transformed this condition from one that was once life-threatening into a manageable chronic illness that many people live with for years.

Prognosis: What to Expect with Chronic Myeloid Leukemia

Receiving a diagnosis of chronic myeloid leukemia naturally brings concerns about the future and how long you can expect to live with this condition. The outlook for people with CML has changed dramatically in recent years, and it’s important to understand what this means for you and your loved ones.[2]

Many people with CML, especially those diagnosed in the chronic phase, may have normal life spans thanks to innovative therapies. Treatment has turned CML from being a potentially life-threatening illness into a chronic condition that medication can manage over the long term. This represents one of the most significant advances in cancer care in recent decades.[2]

The prognosis for CML depends on several important factors. Your age at diagnosis plays a role, as does the phase of the disease when it’s first detected. Most people are diagnosed in the chronic phase, where the disease is developing slowly and is more treatable. The presence of the Philadelphia chromosome (a specific genetic change found in CML cells) and your blood cell counts at diagnosis also influence your outlook.[6]

About 1 in 565 people in the United States will develop chronic myeloid leukemia during their lifetime. It represents roughly 15% of all types of leukemia. While you can develop CML at any age, it typically affects older adults, with a median age of diagnosis around 56 years.[2][7]

⚠️ Important
Your individual prognosis depends on many personal factors that your healthcare team will discuss with you. These factors include the phase of CML at diagnosis, your age, overall health, how well you respond to treatment, and whether you have other medical conditions. Many people diagnosed in the chronic phase with low-risk disease can expect to have the same length of life as people without CML.

It’s worth noting that waiting to find out about your prognosis can be a difficult time. Your specialist doctor will need to wait for test results before they can tell you more about your long-term outlook. This uncertainty is a normal part of the diagnostic process, though it can feel very challenging emotionally.[17]

Natural Progression: How CML Develops Without Treatment

Understanding how chronic myeloid leukemia develops and progresses naturally helps explain why prompt treatment is so important. CML is unusual in that it takes a long time for the disease to get worse on its own. You can have this condition for years before noticing any symptoms, which is why many people learn they have CML only after routine blood test results show unusual blood cell counts.[2]

The disease develops in distinct phases, and how quickly it moves from one phase to another varies from person to person. CML typically starts in what doctors call the chronic phase. During this phase, symptoms are mild or absent, and the disease progresses very slowly. This is the phase when most people receive their diagnosis, and it’s also the phase when treatment works best.[6]

Without treatment, chronic myeloid leukemia can become a life-threatening illness within three to four years. The transition between the chronic phase and more advanced phases may occur gradually over a year or more, or it may happen suddenly in what’s called a blast crisis. When CML progresses, it moves into an accelerated phase, where signs of disease progression become apparent even though it hasn’t yet reached the most severe stage.[2][12]

During the accelerated phase, you may notice progressive enlargement of your spleen, which can cause discomfort or fullness in your abdomen. Your blood counts may worsen, and you might develop increasing numbers of immature white blood cells called blasts in your blood and bone marrow. Some people develop new symptoms like fever that doesn’t go away, bone pain that’s getting worse, or tiny spots of bleeding under the skin.[12]

If left untreated, CML eventually progresses to what’s called the blast phase or blast crisis. This is when the disease behaves more like an acute leukemia, with large numbers of immature blast cells taking over the bone marrow and bloodstream. At this stage, the disease becomes much more difficult to control and requires more intensive treatment approaches.[8]

The good news is that prompt treatment can keep CML from progressing. When treatment is started in the chronic phase, many people can maintain their disease in this stable phase for many years or even decades. This is why early diagnosis and consistent treatment are so crucial for managing this condition effectively.[2]

Possible Complications: What Can Go Wrong

Living with chronic myeloid leukemia means being aware of potential complications that can arise both from the disease itself and, in some cases, from its treatment. Understanding these complications helps you know what warning signs to watch for and when to seek medical attention.

One common complication of CML is anemia, which happens when you don’t have enough healthy red blood cells to carry oxygen throughout your body. Anemia can leave you feeling constantly tired, weak, and short of breath, even with minimal physical activity. This occurs because the abnormal white blood cells in CML crowd out the normal blood cell production in your bone marrow.[2]

Another frequent complication is an enlarged spleen, known medically as splenomegaly. The spleen is an organ on the left side of your abdomen that normally helps filter your blood. In CML, abnormal white blood cells can accumulate in the spleen, causing it to swell significantly. Some people’s spleens become so large that they fill most of the abdomen, causing pain, a feeling of fullness, and making it difficult to eat normal-sized meals. Other people may have only minimal enlargement that doesn’t cause noticeable symptoms.[2][12]

People with CML face an increased risk of developing other types of cancer, sometimes referred to as second cancers. Research has shown that about 30% of people with CML may develop additional cancers during their lifetime. This increased risk means that staying vigilant about cancer screening and reporting any new symptoms to your healthcare team is especially important.[2]

Infections can become more problematic for people with CML because the disease affects white blood cells, which are your body’s primary defense against germs and illness. Even though CML often causes an increase in the total number of white blood cells, many of these cells are abnormal and don’t function properly to fight infections. This means you may be more susceptible to bacterial, viral, and fungal infections than someone without CML.[19]

Bleeding problems can occur in CML, particularly in more advanced stages of the disease. When the bone marrow becomes overwhelmed with abnormal cells, it may not produce enough platelets, which are the blood cells responsible for forming clots to stop bleeding. Low platelet counts can lead to easy bruising, frequent nosebleeds, or prolonged bleeding from minor cuts.[1]

If you’ve had certain treatments for CML, such as a stem cell transplant with donor cells, you may be at risk for a complication called graft versus host disease (GvHD). This happens when the immune cells from the donor attack your body’s tissues, mistaking them for foreign invaders. GvHD can affect many parts of your body, including your skin, digestive system, and liver.[19]

Impact on Daily Life: Living with CML

Chronic myeloid leukemia affects more than just your physical health. It touches every aspect of your daily life, from your energy levels and ability to work, to your emotional wellbeing and relationships with family and friends. Understanding these impacts can help you prepare for and adapt to life with this condition.

One of the most challenging aspects of living with CML is managing fatigue. This isn’t ordinary tiredness that goes away after a good night’s sleep. Fatigue related to CML is a feeling of extreme exhaustion that can come on suddenly and leave you feeling completely drained, both physically and mentally. Many people with CML find that fatigue affects their ability to work full days, keep up with household tasks, or participate in activities they once enjoyed.[19]

The physical symptoms of CML can interfere with everyday activities. Feeling full quickly when eating can make it difficult to enjoy meals with family or social gatherings centered around food. Pain or discomfort from an enlarged spleen may limit your ability to engage in physical activities or exercise. Night sweats can disrupt your sleep, leaving you tired during the day and affecting your ability to concentrate at work or enjoy leisure time.[1]

Taking daily medication becomes a central part of your routine when you have CML. Unlike some cancers where treatment ends after a certain period, many people with CML need to take targeted therapy drugs every day, often for years or indefinitely. Remembering to take these medications consistently, managing their side effects, and attending regular medical appointments requires significant time and mental energy.[17]

The emotional impact of living with a chronic blood cancer can be substantial. Many people experience anxiety about their future, worry about whether their treatment is working, and feel uncertain about what comes next. Unlike cancers that might go into remission and allow you to resume a “cancer-free” life, CML is different. It will always be part of your life, even when it’s well-controlled. Learning to adjust to this reality takes time and emotional resilience.[17]

Work and study can present special challenges for people with CML. While many people continue working throughout their treatment, fatigue and side effects from medication may require adjustments to your schedule or responsibilities. You might need to have difficult conversations with employers about your condition, request flexible working arrangements, or even consider reducing your hours. Students may need to discuss accommodations with their educational institutions.[19]

Social relationships can shift when you’re living with CML. Some people find it difficult to explain their condition to friends and family, especially because they may not look sick. The invisible nature of the disease can make it hard for others to understand why you might need to cancel plans at the last minute or can’t participate in certain activities. Finding the balance between maintaining your social connections and respecting your body’s limitations is an ongoing challenge.[17]

There are practical strategies that can help you cope with these limitations. Evidence shows that regular gentle exercise, such as walking, can actually help with fatigue rather than making it worse. Learning to pace yourself and not take on too much at once helps conserve your energy for the activities that matter most to you. Some people find it helpful to plan their most demanding tasks for times of day when they typically have more energy.[19]

Many people with CML need to take special precautions in their daily lives. Some medications used to treat CML are photosensitive, meaning they increase your risk of sun damage and skin cancer. This may require you to avoid prolonged sun exposure, wear protective clothing and hats, and use high-SPF sunscreen regularly, even on cloudy days. If you’ve had a stem cell transplant, sun protection becomes even more important.[19]

⚠️ Important
Living with a chronic condition like CML is different from many other cancers. You often don’t look ill, and people around you might not even know you have cancer. This can make it harder to seek support or explain to others why you’re struggling. Remember that it’s natural to experience different feelings as you come to terms with your diagnosis, and these feelings are likely to come and go over time. Don’t hesitate to reach out for support when you need it.

Despite these challenges, many people with CML find ways to live full and meaningful lives. The key is often learning to be flexible, listening to your body’s signals, and accepting that some days will be better than others. Building a support network of family, friends, healthcare providers, and other people living with CML can make a significant difference in your ability to cope with the daily realities of this condition.[17]

Support for Family: Helping Your Loved One Through Clinical Trials

If your family member has chronic myeloid leukemia, you may feel uncertain about how to help, especially when it comes to understanding treatment options like clinical trials. Your support and involvement can make a meaningful difference in their journey with this disease.

Clinical trials are research studies that test new treatments or new ways of using existing treatments for CML. They play a crucial role in advancing our understanding of how to manage this disease more effectively. Many of the treatments that have transformed CML from a life-threatening condition into a manageable chronic illness were developed through clinical trials. Understanding what clinical trials are and how they work can help you support your loved one in making informed decisions about their care.[3]

Research for CML is actively looking into improving treatment outcomes. Scientists are working on developing new targeted therapies, understanding why some people’s CML responds better to treatment than others, and finding ways to minimize side effects while maintaining effectiveness. Some clinical trials focus on whether people who have achieved very good responses to treatment might be able to safely stop their medication, which would be a significant quality of life improvement.[3]

As a family member, you can help your loved one find information about clinical trials. Start by encouraging them to discuss clinical trial options with their healthcare team. Their specialist doctor or nurse will know about trials that might be suitable based on the phase of their CML, their response to current treatment, and their overall health status. The healthcare team can explain the potential benefits and risks of participating in a trial.[3]

Helping with practical aspects of trial participation can be invaluable. Clinical trials often require additional hospital visits for monitoring and tests beyond what standard care would involve. You might offer to accompany your loved one to these appointments, help them keep track of their schedule, or provide transportation. Having someone to listen and take notes during appointments can also be helpful, as it’s easy to feel overwhelmed and forget information when you’re the patient.

Your emotional support matters enormously throughout the treatment process, whether or not your family member participates in a clinical trial. Living with CML means dealing with ongoing uncertainty about how well treatment is working and what the future holds. Many people with chronic conditions like CML feel pressured to “just carry on as normal,” which can make it harder for them to express concerns or ask for help. Let your loved one know that you’re there to listen without judgment, whether they want to talk about their fears, their frustrations with side effects, or their hopes for the future.[17]

Understanding that CML is different from many other cancers can help you provide better support. Unlike cancers that might be treated and then go into remission, allowing the person to return to a “cancer-free” life, CML is a chronic condition that will always be present, even when it’s well-controlled. There isn’t typically an end point to treatment or a celebration of being “cancer-free.” This ongoing nature of the disease can be emotionally draining for patients, and recognizing this reality helps you understand what your loved one is experiencing.[17]

You can also help by learning about CML alongside your family member. Understanding the basics of the disease, its phases, how treatment works, and what side effects to watch for makes you a more effective support person. You’ll be better equipped to notice concerning changes and encourage your loved one to report them to their healthcare team. However, be mindful not to become overly focused on every symptom or constantly worry, as this anxiety can transfer to your loved one.

Practical help with daily tasks can be especially valuable when your family member is experiencing fatigue or other side effects. This might include helping with household chores, preparing meals, or taking over responsibilities that they’re finding difficult to manage. Even small gestures like doing the grocery shopping or driving them to appointments can reduce their stress and help them conserve energy.

Remember to take care of yourself as well. Supporting someone with a chronic illness can be emotionally and physically demanding. Make sure you have your own support network, take breaks when you need them, and don’t neglect your own health and wellbeing. Being a caregiver is valuable work, but you can only provide good support if you’re also looking after yourself.[17]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Imatinib – A tyrosine kinase inhibitor used as the main targeted therapy for chronic myeloid leukemia
  • Dasatinib – A tyrosine kinase inhibitor used for treating CML, particularly when first-line therapy doesn’t work well
  • Nilotinib – A tyrosine kinase inhibitor used for treating various phases of chronic myeloid leukemia
  • Bosutinib – A tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia
  • Hydroxycarbamide – A medication that may be used in CML treatment and requires sun safety precautions due to photosensitivity

Ongoing Clinical Trials on Chronic myeloid leukaemia

  • Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Bulgaria Czechia Denmark France Germany +8
  • Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

    Recruiting

    1 1 1
    Investigated diseases:
    Italy Spain
  • Study of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Poland Spain
  • Study on Stopping Dasatinib in Patients with Chronic Myeloid Leukemia After a Previous Attempt to Stop Treatment

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France The Netherlands
  • Asciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Poland Spain
  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Not yet recruiting

    1 1 1 1
    France
  • Study of ponatinib and azacitidine combination treatment in patients with accelerated phase or blast crisis chronic myelogenous leukemia

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia

    Not recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy The Netherlands
  • Study of Asciminib Treatment for Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

References

https://www.mayoclinic.org/diseases-conditions/chronic-myelogenous-leukemia/symptoms-causes/syc-20352417

https://my.clevelandclinic.org/health/diseases/21845-chronic-myelogenous-leukemia-cml

https://www.cancerresearchuk.org/about-cancer/chronic-myeloid-leukaemia-cml

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/leukaemia/chronic-myeloid-leukaemia/

https://www.cancer.gov/types/leukemia/patient/cml-treatment-pdq

https://cancer.ca/en/cancer-information/cancer-types/chronic-myeloid-leukemia-cml

https://www.ncbi.nlm.nih.gov/books/NBK531459/

https://medlineplus.gov/chronicmyeloidleukemia.html

https://www.cancer.org/cancer/types/chronic-myeloid-leukemia/treating.html

https://www.cancer.gov/types/leukemia/patient/cml-treatment-pdq

https://cancer.ca/en/cancer-information/cancer-types/chronic-myeloid-leukemia-cml/treatment

https://www.ncbi.nlm.nih.gov/books/NBK65916/

https://my.clevelandclinic.org/health/diseases/21845-chronic-myelogenous-leukemia-cml

https://www.cancerresearchuk.org/about-cancer/chronic-myeloid-leukaemia-cml/treatment/treatment-decisions

https://www.mskcc.org/news/newly-approved-pill-for-chronic-myeloid-leukemia-offers-greater-hope-for-cure

https://www.mayoclinic.org/diseases-conditions/chronic-myelogenous-leukemia/diagnosis-treatment/drc-20352422

https://www.cancerresearchuk.org/about-cancer/chronic-myeloid-leukaemia-cml/living-with/daily-life

https://www.cancer.org/cancer/types/chronic-myeloid-leukemia/after-treatment/follow-up.html

https://bloodcancer.org.uk/understanding-blood-cancer/leukaemia/chronic-myeloid-leukaemia-cml/looking-after-yourself-cml/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can chronic myeloid leukemia be cured completely?

Modern targeted therapies called tyrosine kinase inhibitors have transformed CML into a manageable chronic condition. Many people with CML can achieve very good responses to treatment and maintain their disease in the chronic phase for many years. Some people may eventually be able to stop treatment after achieving deep molecular responses sustained over time, though this is carefully monitored by healthcare teams. The goal is long-term disease control rather than necessarily achieving a traditional “cure.”

How long does it take for CML to progress without treatment?

Without treatment, chronic myeloid leukemia can become a life-threatening illness within three to four years. However, it takes a long time for CML to get worse initially – you can have the condition for years before noticing symptoms. This is why many people discover they have CML through routine blood tests before they feel ill. Prompt treatment keeps CML from progressing and can maintain the disease in the stable chronic phase for extended periods.

Will I have a normal lifespan if I’m diagnosed with CML?

Many people with CML, especially those diagnosed in the chronic phase with low-risk disease, may have normal life spans thanks to innovative therapies. Treatment has turned CML from a potentially life-threatening illness into a chronic condition that medication can manage. Your individual prognosis depends on several factors including your age, the phase of CML at diagnosis, how well you respond to treatment, and your overall health.

What is the Philadelphia chromosome and why is it important?

The Philadelphia chromosome is a genetic change found in about 90-95% of people with CML. It results from a swap of genetic material between chromosomes 9 and 22, creating a new abnormal gene called BCR-ABL. This gene produces an abnormal protein that acts like a faulty switch, causing bone marrow cells to divide and multiply uncontrollably. The Philadelphia chromosome is not inherited or passed from parent to child – it happens during a person’s lifetime. Testing for this chromosome helps confirm the diagnosis of CML.

Can I continue working if I have chronic myeloid leukemia?

Many people with CML continue working throughout their treatment, though you may need to make some adjustments. Fatigue and medication side effects might require flexible working arrangements, reduced hours, or modifications to your responsibilities. The impact on work varies greatly between individuals – some people find their CML doesn’t significantly affect their daily routine, while others need more substantial accommodations. It’s important to communicate with your employer about your needs and to pace yourself to manage your energy levels effectively.

🎯 Key takeaways

  • Chronic myeloid leukemia progresses slowly and many people live for years without symptoms before diagnosis through routine blood tests
  • Modern targeted therapies have transformed CML from a life-threatening disease into a manageable chronic condition with potential for normal lifespan
  • The Philadelphia chromosome, found in 90-95% of CML cases, is not inherited but develops during a person’s lifetime
  • Without treatment, CML can become life-threatening within 3-4 years, but prompt treatment keeps the disease stable in the chronic phase
  • Living with CML means adapting to taking daily medication indefinitely and attending regular monitoring appointments throughout life
  • Fatigue is one of the most challenging symptoms, but gentle regular exercise like walking can actually help rather than make it worse
  • People with CML may have increased risk of developing other cancers, making vigilant screening important
  • The only known risk factor for CML is exposure to high levels of radiation, which applies to very few people